Point of care diagnostics is one of the most dynamic parts of the diagnostics industry and an area where several major competitors are battling for market share. Point-of-care testing (POC) is defined as diagnostic testing at or near the site of patient care. Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics.

Manufacturers are increasingly introducing minimally invasive tests that can be easily performed on a patient’s saliva, urine, breath or other bodily by-products. This report covers the following POC test segments with current market size and forecasts:

• Glucose
• Pregnancy/Ovulation
• Coagulation/PT
• Fecal Occult Blood
• Drugs of Abuse
• H. pylori
• HIV
• Cholesterol
• Other
• Glucose
• Critical Care
• Pregnancy
• Infectious Diseases
• Cardiac Markers
• Cholesterol/Lipids
• Coagulation/PT, ACT
• bA1c
• Hemoglobin
• Fecal occult blood
• Drugs of Abuse
• Bilirubin

In addition to the total POC diagnostic market, the report also covers the impact on POC markets of the following trends:

• Miniturization
• Digital Technology
• Aging Population
• POC Advantages and Disadvantages
• Emerging World Markets
• Consolidation in IVD
• Physician Office Labs
• Retail Clinics
• Wellness Initiatives

As a worldwide report, this report breaks up revenue for POC diagnostics in the following regions:

• U.S.
• Europe
• Asia
• Rest of World

This report is the result of primary and secondary research - interviews with experts in the POC diagnostics industry, a review of annual reports and news articles in the area of POC diagnostics, and the analysis of Kalorama's diagnostics experts, who have observed the industry for the past decade. The most important part of Kalorama's anlaysis is its superior analysis of company activities and their true significance in the marketplace. The following companies are examined in detail:

• 77 Elektronika Kft
• Abbott Diagnostics
• Acrongenomics Inc.
• AgaMatrix, Inc
• Agilent Technologies Inc
• Alere Medical Inc
• ARKRAY
• Axis-Shield plc
• Bayer Diabetes Care
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• BIOSAFE Medical Technologies, Inc.
• Biosign Technologies Inc.
• BodyTel Scientific Inc.
• Chembio Diagnostics, Inc.
• Chempaq A/S
• Cholestech Corporation
• Concateno Plc / Cozart Plc
• Crescent Diagnostics Ltd.
• DexCom, Inc.
• Diabetech, LP
• Diazyme Laboratories
• DNA Direct, Inc.
• DNAFORM
• DNAPrint Genomics, Inc.
• EKF-diagnostic GmbH
• Epocal, Inc.
• Gentag Inc.
• Genzyme Corporation
• GlucoLight Corporation
• GlucoStats System
• GlucoTec, Inc.
• HealthPia America
• Heidelberger-Medical-Marketing GmbH (HMM GmbH)
• HemoCue AB
• Integrity Applications Ltd.
• Inverness Medical Innovations
• Lifescan Inc.
• Luminous Medical, Inc.
• Medtronic Inc.
• A. Menarini Diagnostics
• Menssana Research, Inc.
• Micronics Inc.
• Multilyte Limited
• MycroLab Pty Ltd.
• Neuroptix Corporation
• OraSure Technologies, Inc.
• OrSense Ltd.
• OrthoClinical Diagnostics.
• Philips Medical Systems
• PointCare Technologies, Inc.
• Polymedco, Inc.
• Quadraspec
• Qualigen, Inc.
• Quidel Corporation
• Quotient Diagnostics
• RainDance Technologies, Inc. (RDT)
• Roche Diagnostics
• SpheroSense Technologies Inc
• Taidoc Technology Corp.
• Veralight

Related Reports:

The Worldwide Market for Cancer Diagnostics, 4th Edition
Apr 1, 2010 - KLI2504623 - $4,200.00

The Global Market for Medical Devices
Mar 1, 2010 - KLI2592223 - $1,500.00

Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
Nov 1, 2009 - KLI2403357 - $3,995.00

2009 Worldwide Diagnostics Market Research Bundle
Oct 1, 2009 - KLI2401913 - $5,995.00

The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
Oct 1, 2009 - KLI2435380 - $3,500.00

Implant-Based Dental Reconstruction: World Dental Implant and Bone Graft Market, 3rd Edition
Sep 1, 2009 - KLI2284095 - $3,500.00

Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Jun 1, 2009 - KLI2155319 - $3,995.00

H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)
May 1, 2009 - KLI2241990 - $800.00

The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
May 1, 2009 - KLI2218043 - $3,995.00

In Vitro Diagnostics in a Recessionary Economy: IVD Market Forecasts, Analysis and Success Strategies
May 1, 2009 - KLI2155316 - $1,995.00